文献速递慢阻肺

基于最低资源的居家肺康复治疗慢阻肺的经济学分析

Home-based pulmonary rehabilitation for COPD using minimal resources: An economic analysis.
PubMed 文献 · Respirology · 2019-08-16

本研究在随机对照等效试验基础上,从卫生系统视角前瞻性比较慢阻肺患者居家与中心肺康复的成本效果与成本效用。结果显示居家组成本更低且效用与效果点估计更优,居家模型在零意愿支付阈值下具有成本效用的概率为78%,是传统中心方案的可及替代。

要点

  • 居家肺康复在成本、QALY和6分钟步行距离变化上点估计均优于中心肺康复。
  • 居家模型在零意愿支付阈值下具有成本效用的概率为78%。
  • 完成肺康复项目与随后12个月医疗费用显著降低相关。

核心结论

  • 居家肺康复为无法获得传统中心肺康复的慢阻肺患者提供了一种成本有效的替代模式。

研究设计与样本

  • 前瞻性经济学分析,与随机对照等效试验并行,从卫生系统视角开展。
  • 参与者为转诊至肺康复的稳定期慢阻肺成人,接受标准8周门诊中心肺康复或新型居家肺康复。
  • 在项目开始前、完成后即刻及完成后12个月进行临床评估,并提供效用与效果数据。

主要发现

  • 组间均值差点估计:效用为0.025(-0.038至0.086)QALY,居家组更优。
  • 组间均值差点估计:效果为14 m(-11至39)Δ6MWD,居家组更优。
  • 成本效用分析显示63%的估计值落在优势东南象限,零意愿支付阈值下居家模型具有成本效用的概率为78%。
  • 结果在一系列敏感性分析中稳健,完成项目与随后12个月医疗费用显著降低相关。

临床怎么用

  • 对于无法获得传统中心肺康复的慢阻肺患者,可考虑提供居家肺康复作为替代方案。
  • 居家肺康复可能降低卫生系统成本并改善或等效维持效用与运动能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: This study aimed to compare the cost-effectiveness and cost-utility of home and centre-based pulmonary rehabilitation for adults with stable chronic obstructive pulmonary disease (COPD). METHODS: Prospective economic analyses were undertaken from a health system perspective alongside a randomized controlled equivalence trial in which participants referred to pulmonary rehabilitation undertook a standard 8-week outpatient centre-based or a new home-based programme. Participants underwent clinical assessment prior to programme commencement, immediately following completion and 12 months following programme completion. They provided data for utility (quality-adjusted life years (QALY) determined using SF6D (utility scores for health states) calculated from 36-Item Short Form Health Survey version 2) and effectiveness (change in distance walked on 6-min walk test (Δ6MWD) following pulmonary rehabilitation ). Individual-level cost data for the 12 months following programme completion was sourced from healthcare administration and government databases. RESULTS: Between-group mean difference point estimates for cost (-$4497 (95% CI: -$12 250 to $3257), utility (0.025 (-0.038 to 0.086) QALY) and effectiveness (14 m (-11 to 39) Δ6MWD) favoured the home-based group. Cost-utility analyses demonstrated 63% of estimates falling in the dominant southeast quadrant and the probability that the new home-based model was cost-effective at a $0 threshold for willingness to pay was 78%. Results were robust to a range of sensitivity analyses. Programme completion was associated with significantly lower healthcare costs in the following 12 months. CONCLUSION: Home-based pulmonary rehabilitation provides a cost-effective alternative model for people with COPD who cannot access traditional centre-based programmes.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Burge AT, Holland AE, McDonald CF, et al. Home-based pulmonary rehabilitation for COPD using minimal resources: An economic analysis. Respirology. 2019. PMID: 31418515. doi:10.1111/resp.13667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。